Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8772)
All Articles published online
|
Publishing Process of This Article
|
May 24, 2020 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pinheiro FD, Teixeira AF, de Brito BB, da Silva FAF, Santos MLC, de Melo FF. Immunotherapy – new perspective in lung cancer. World J Clin Oncol 2020; 11(5): 250-259 [PMID: 32728528 DOI: 10.5306/wjco.v11.i5.250] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v11/i5/250.htm |
| Number | Citing Articles |
| 1 |
Marnix J.A. Rasing, Max Peters, Mieke J. Aarts, Gerarda J.M. Herder, Anne S.R. van Lindert, Franz M.N.H. Schramel, Femke S. van der Meer, Joost J.C. Verhoeff, Peter S.N. van Rossum. Adjuvant Treatment Following Irradical Resection of Stage I-III Non-small Cell Lung Cancer: A Population-based Study. Current Problems in Cancer 2022; 46(1): 100784 doi: 10.1016/j.currproblcancer.2021.100784
|
| 2 |
Irena Wieleba, Kamila Wojas-Krawczyk, Izabela Chmielewska, Magdalena Wójcik-Superczyńska, Paweł Krawczyk, Janusz Milanowski. In vitro preliminary study on different anti-PD-1 antibody concentrations on T cells activation. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-12136-1
|
| 3 |
Milena von Kutzleben, Jan Christoph Galuska, Andreas Hein, Frank Griesinger, Lena Ansmann. Needs of Lung Cancer Patients Receiving Immunotherapy and Acceptance of Digital and Sensor-Based Scenarios for Monitoring Symptoms at Home—A Qualitative-Explorative Study. International Journal of Environmental Research and Public Health 2022; 19(15): 9265 doi: 10.3390/ijerph19159265
|
| 4 |
Jun Lu, Yanwei Zhang, Yuqing Lou, Bo Yan, Benkun Zou, Minjuan Hu, Yanan Wang, Ya Chen, Zhengyu Yang, Huimin Wang, Wei Zhang, Baohui Han. ctDNA-Profiling-Based UBL Biological Process Mutation Status as a Predictor of Atezolizumab Response Among TP53-Negative NSCLC Patients. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.723670
|
| 5 |
Evgenii G. Skurikhin, Olga Pershina, Natalia Ermakova, Angelina Pakhomova, Mariia Zhukova, Edgar Pan, Lubov Sandrikina, Darius Widera, Lena Kogai, Nikolai Kushlinskii, Aslan Kubatiev, Sergey G. Morozov, Alexander Dygai. Cell Therapy with Human Reprogrammed CD8+ T-Cells Has Antimetastatic Effects on Lewis Lung Carcinoma in C57BL/6 Mice. International Journal of Molecular Sciences 2022; 23(24): 15780 doi: 10.3390/ijms232415780
|
| 6 |
Jun Lu, Runbo Zhong, Yuqing Lou, Minjuan Hu, Zhengyu Yang, Yanan Wang, Ya Chen, Benkun Zou, Wei Zhang, Huimin Wang, Baohui Han. TP53 Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.732125
|
| 7 |
Manlio Mencoboni, Marcello Ceppi, Marco Bruzzone, Paola Taveggia, Alessia Cavo, Francesca Scordamaglia, Marina Gualco, Rosa Angela Filiberti. Effectiveness and Safety of Immune Checkpoint Inhibitors for Patients with Advanced Non Small-Cell Lung Cancer in Real-World: Review and Meta-Analysis. Cancers 2021; 13(6): 1388 doi: 10.3390/cancers13061388
|
| 8 |
Fahdi Kanavati, Gouji Toyokawa, Seiya Momosaki, Hiroaki Takeoka, Masaki Okamoto, Koji Yamazaki, Sadanori Takeo, Osamu Iizuka, Masayuki Tsuneki. A deep learning model for the classification of indeterminate lung carcinoma in biopsy whole slide images. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87644-7
|